Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study

Abstract

Background Adiposity is a strong risk factor for cancer incidence and mortality. However, most of the evidence available has focused on body mass index (BMI) as a marker of adiposity. There is limited evidence on relationships of cancer with other adiposity markers, and if these associations are linear or not. The aim of this study was to investigate the associations of six adiposity markers with incidence and mortality from 24 cancers by accounting for potential non-linear associations. Methods A total of 437,393 participants (53.8% women; mean age 56.3 years) from the UK Biobank prospective cohort study were included in this study. The median follow-up was 8.8 years (interquartile range 7.9 to 9.6) for mortality and 9.3 years (IQR 8.6 to 9.9) for cancer incidence. Adiposity-related exposures were BMI, body fat percentage, waist-hip ratio, waist-height ratio, and waist and hip circumference. Incidence and mortality of 24 cancers sites were the outcomes. Cox proportional hazard models were used with each of the exposure variables fitted separately on penalised cubic splines. Results During follow-up, 47,882 individuals developed cancer and 11,265 died due to cancer during the follow-up period. All adiposity markers had similar associations with overall cancer incidence. BMI was associated with a higher incidence of 10 cancers (stomach cardia (hazard ratio per 1 SD increment 1.35, (95% CI 1.23; 1.47)), gallbladder (1.33 (1.12; 1.58)), liver (1.27 (1.19; 1.36)), kidney (1.26 (1.20; 1.33)), pancreas (1.12 (1.06; 1.19)), bladder (1.09 (1.04; 1.14)), colorectal (1.10 (1.06; 1.13)), endometrial (1.73 (1.65; 1.82)), uterine (1.68 (1.60; 1.75)), and breast cancer (1.08 (1.05; 1.11))) and overall cancer (1.03 (1.02; 1.04)). All these associations were linear except for breast cancer in postmenopausal women. Similar results were observed when other markers of central and overall adiposity were used. For mortality, nine cancer sites were linearly associated with BMI and eight with waist circumference and body fat percentage. Conclusion Adiposity, regardless of the marker used, was associated with an increased risk in 10 cancer sites.

Effects of exercise training on obesity‐related parameters in people with intellectual disabilities: systematic review and meta‐analysis

“…Overweight and obesity, defined as a body mass index (BMI) over 25 or 30 kg/m 2 , respectively, are an excessive fat accumulation (i.e. adiposity) that is associated with poor health outcomes, including an increased risk of incidence and mortality from cancers (Parra-Soto et al 2021) and cardiovascular diseases (Dwivedi et al 2020). Because of the important health burden and the economic costs to the healthcare systems worldwide derived from obesity, it is a health condition that needs treatment and, more importantly, prevention (Meldrum et al 2017).…”

Diet quality indices and gastrointestinal cancer risk: results from the Lifelines study

“…Models were adjusted for age (continuous; years), height (continuous; cm) [ 25 ], family history of cancer (yes, no), educational level (categorical; low, medium, and high), smoking (continuous; pack/year), BMI (continuous; kg/m 2 , [ 26 ]), physical activity (continuous; leisure [i.e. cycling, dancing], household [i.e.…”

Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations

“…Furthermore, waist circumference is associated with HCC beyond BMI. In fact, adiposity-related markers such as body fat percentage, waist–hip ratio, and waist–height ratio, were all positively related to liver cancer in 437,393 participants from the UK Biobank prospective cohort [ 32 ]. In a meta-analysis including five prospective cohort studies, waist circumference was positively associated with the risk of liver cancer in a dose-response manner [ 33 ].…”